Applied nutritional investigationEffect of onion peel extract on endothelial function and endothelial progenitor cells in overweight and obese individuals

- This study was a randomized double-blind, placebo-controlled prospective trial to determine whether 12-wk intake of onion peel extract (OPE) containing quercetin would improve endothelial function in healthy overweight and obese individuals.
- Consumption of OPE induced an improvement in endothelial dysfunction and circulating endothelial progenitor cells levels.
- Interestingly, when flow-mediated dilation was divided into quartiles, rate of patients with endothelial dysfunction defined as lowest quartile (cutoff value, 8.6%) of flow-mediated dilation was improved by OPE intake.

ObjectivesAcute or chronic intake of polyphenol-rich foods has been reported to improve endothelial function. Quercetin, found abundantly in onion, is a potent antioxidant flavonoid. The aim of this study was to investigate whether consumption of onion peel extract (OPE) improves endothelial function in healthy overweight and obese individuals.MethodsThis was a randomized double-blind, placebo-controlled study. Seventy-two healthy overweight and obese participants were randomly assigned to receive a red, soft capsule of OPE (100 mg quercetin/d, 50 mg quercetin twice daily; n = 36 participants) or an identical placebo capsule (n = 36) for 12 wk. Endothelial function, defined by flow-mediated dilation (FMD), circulating endothelial progenitor cells (EPCs) by flow cytometry, and laboratory test were determined at baseline and after treatment.ResultsBaseline characteristics and laboratory findings did not significantly differ between the two groups. Compared with baseline values, the OPE group showed significantly improved FMD at 12 wk (from 12.5 ± 5.2 to 15.2 ± 6.1; P = 0.002), whereas the placebo group showed no difference. Nitroglycerin-mediated dilation did not change in either group. EPC counts (44.2 ± 25.6 versus 52.3 ± 18.6; P = 0.005) and the percentage of EPCs were significantly increased in the OPE group. When FMD was divided into quartiles, rate of patients with endothelial dysfunction defined as lowest quartile (cutoff value, 8.6%) of FMD improved from 26% to 9% by OPE.ConclusionMedium-term administration of OPE an improvement in FMD and circulating EPCs.